Current canonical position

Should people be allowed to sell one of their kidneys?

NO −1000+100 YES

+24

A synthesis of reasoning, not a probability or recommendation.

Yes — but only under strict regulation.

The strongest argument for allowing compensated kidney donation is that it could save lives and reduce suffering by increasing kidney supply while respecting adult bodily autonomy. The score is only mildly positive because exploitation, unequal pressure on the poor, and the risk that real-world regulation would fail are serious objections.

Where do you land?

YES

Strongest arguments

For

Against

Recent contributions

Earlier discussions stay here. Open one to continue it.

Anonymous · 12:43 am

It could undermine programmes to help poor and unemployed because prevailing society sentiment might become that people should just sell a kidney if no job. Also, peple will stop donating, as you said, and that coudl put price of a kidney really high and might actually make it harder for poorer people who need a kidney to access one

Moved 6 points toward YES +18 → +24

2 canonical revisions preserved.

Read the full analysis

On the best reading of the question, the case for permission is stronger when it refers to a regulated system for living kidney donation rather than a laissez-faire organ market. Kidney shortage is a grave harm, transplantation is often substantially better than long-term dialysis for eligible patients, and outright prohibition already coexists with black markets that are typically less safe and more exploitative. Those points make some form of legal, compensated system morally attractive. But the objections are not merely symbolic: financial desperation can distort consent, burdens would likely fall disproportionately on poorer people, and any actual market could be captured by brokers, weak oversight, or social pressure. So the current synthesis leans toward a cautious yes for regulated compensation, not a broad endorsement of organ commodification.

Important facts

People can often live with one kidney, but living kidney donation involves real surgical risks and some long-term health risks.
Many countries face persistent shortages of transplantable kidneys, leaving patients on waiting lists or long-term dialysis.
For many eligible patients, kidney transplantation generally offers better survival and quality of life than long-term dialysis.
Illegal organ markets and trafficking have existed and are associated with abuse, poor screening, and weak follow-up.
Iran has operated a form of compensated kidney donation, but the evidence about its effectiveness, fairness, and transferability is contested.

Uncertainties

How much a regulated compensation system would actually increase kidney supply relative to current alternatives.
Whether regulation can meaningfully protect poor or indebted donors from coercion, concealment, and unfair pressure.
Whether payment would substantially reduce altruistic donation or trust in transplantation institutions.
The long-term medical, psychological, and economic outcomes for compensated donors, especially vulnerable donors.
How much weight should be given to anti-commodification and dignity-based objections even if harms could be reduced empirically.
Whether legalization would create broader social pressure on poor people or weaken support for social welfare and employment assistance.

Assumptions

The question concerns competent adults capable of informed consent, not minors or incapacitated persons.
The question concerns sale of one kidney only, where the donor remains alive, not organs whose removal is incompatible with life.
The main comparison is between prohibition plus existing shortages and illicit trade, versus a regulated compensation system, not versus a perfectly functioning altruistic donation system.
Bodily autonomy has substantial moral weight but can be limited to prevent serious exploitation or systemic injustice.